The Centers for Medicare and Medicaid Services plans to terminate four demonstration projects by the end of 2025, closing out ...
The acquired portfolio consists of 13 ANDAs already approved by the Food and Drug Administration and one pending approval.
A study found Indian generics sold in the US between 2009-2018 linked to a 54% higher risk of serious side effects compared ...
Mankind Pharma has launched generic versions of diabetes medication Empagliflozin under brand names Empaglyde, Empagreat, and ...
Glenmark and Alkem Labs launched the generic version as well as its Fixed Dose Combination (FDCs) of Empagliflozin in India.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback